000 01249 a2200361 4500
005 20250517221231.0
264 0 _c20190201
008 201902s 0 0 eng d
022 _a1432-2161
024 7 _a10.1007/s00256-018-2980-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAdams, Chad C
245 0 0 _aHow we do it: shifting MR arthrogram compounding from the fluoroscopy suite to the sterile pharmacy.
_h[electronic resource]
260 _bSkeletal radiology
_cMar 2019
300 _a445-448 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aContrast Media
_xchemistry
650 0 4 _aCost Savings
650 0 4 _aDrug Compounding
_xeconomics
650 0 4 _aFluoroscopy
650 0 4 _aGadolinium DTPA
_xchemistry
650 0 4 _aGuideline Adherence
650 0 4 _aHumans
650 0 4 _aIopamidol
_xchemistry
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aPharmacy Service, Hospital
_xeconomics
700 1 _aLoewen, Matthew J
700 1 _aBreckenridge, Ian A
700 1 _aBesich-Carter, Jane E
700 1 _aBush, Lisabeth A
773 0 _tSkeletal radiology
_gvol. 48
_gno. 3
_gp. 445-448
856 4 0 _uhttps://doi.org/10.1007/s00256-018-2980-y
_zAvailable from publisher's website
999 _c28475569
_d28475569